Humana (US.HUM)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.HUM · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 92.1% | ↑ |
| ROE | 9.8% | → |
| Cash Conversion | 171.3% | ↑ |
| D/E Ratio | 0.74 | ↓ |
| Gross Margin | 0.0% | ↓ |
US.HUM (Humana) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 92.1% ↑ ROE 9.8% → Cash Conversion 171.3% ↑ D/E Ratio 0.74 ↓ Gross Margin 0.0% ↓
Key Metrics
US.HUM (Humana) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 92.1% ↑ROE 9.8% →Cash Conversion 171.3% ↑D/E Ratio 0.74 ↓Gross Margin 0.0% ↓Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies